In male mice, a low dose of DEHP activated the hepatic 14-3-3η/NF-κB positive feedback loop, which in turn modified the secretory proteome associated with bone differentiation and elevated IL-6 and CXCL1 levels, leading to HOD. Here, CXCL1 is linked to hypopigmentation, organomegaly, and delayed myelination and development.